Sue Wallcraft is a member of the Audit and Risk Management Committee and the Remuneration Committee. Sue is an experienced general counsel and company secretary with over 25 years’ experience in the pharmaceutical industry and health charities. She is a qualified English solicitor and brings significant legal and governance knowledge to the board. Sue is currently General Counsel and Company Secretary for Vernalis (R&D) Limited, a non-executive director of Medicines Discovery Catapult.
Susan Wallcraft
Latest news
-
LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
-
LifeArc Translational Science Summit 2026: Charting new paths for rare disease
-
From curiosity to career: LifeArc placement students share their stories for British Science Week